These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15161075)

  • 1. Comparison of different routes of vaccination for eliciting antibody responses in the human stomach.
    Johansson EL; Bergquist C; Edebo A; Johansson C; Svennerholm AM
    Vaccine; 2004 Feb; 22(8):984-90. PubMed ID: 15161075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of B cell responses in the stomach of Helicobacter pylori- infected subjects after oral cholera vaccination.
    Mattsson A; Lönroth H; Quiding-Järbrink M; Svennerholm AM
    J Clin Invest; 1998 Jul; 102(1):51-6. PubMed ID: 9649556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral vaccination against Helicobacter pylori with recombinant cholera toxin B-subunit.
    Kubota E; Joh T; Tanida S; Sasaki M; Kataoka H; Watanabe K; Itoh K; Oshima T; Ogasawara N; Togawa S; Wada T; Yamada T; Mori Y; Fujita F; Shimura T; Ohara H; Isaka M; Yasuda Y; Itoh M
    Helicobacter; 2005 Aug; 10(4):345-52. PubMed ID: 16104951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice.
    Nyström J; Raghavan S; Svennerholm AM
    Microbes Infect; 2006 Feb; 8(2):442-9. PubMed ID: 16243563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal vaccination strategies for women.
    Kozlowski PA; Cu-Uvin S; Neutra MR; Flanigan TP
    J Infect Dis; 1999 May; 179 Suppl 3():S493-8. PubMed ID: 10099127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response in mice immunized by mucosal routes with formalin-inactivated enteropathogenic Escherichia coli (EPEC) strains.
    Drago-Serrano ME; Manjarréz Hernandez HA; Gavilanes Parra S; Sainz Espuñes Tdel R
    Rev Latinoam Microbiol; 2004; 46(1-2):17-23. PubMed ID: 17061522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection Against
    Pan X; Ke H; Niu X; Li S; Lv J; Pan L
    Front Immunol; 2018; 9():1003. PubMed ID: 29867978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
    Nyström J; Svennerholm AM
    Vaccine; 2007 Mar; 25(14):2591-8. PubMed ID: 17239498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection.
    Kleanthous H; Myers GA; Georgakopoulos KM; Tibbitts TJ; Ingrassia JW; Gray HL; Ding R; Zhang ZZ; Lei W; Nichols R; Lee CK; Ermak TH; Monath TP
    Infect Immun; 1998 Jun; 66(6):2879-86. PubMed ID: 9596763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
    Xu G; Wang S; Zhuang L; Hackett A; Gu L; Zhang L; Zhang C; Wang H; Huang Z; Lu S
    Vaccine; 2009 Jun; 27(29):3821-30. PubMed ID: 19443090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Infect Immun; 2000 Oct; 68(10):5749-55. PubMed ID: 10992481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice.
    Zhao W; Wu W; Xu X
    Vaccine; 2007 Nov; 25(44):7664-73. PubMed ID: 17913305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans.
    Johansson EL; Wassén L; Holmgren J; Jertborn M; Rudin A
    Infect Immun; 2001 Dec; 69(12):7481-6. PubMed ID: 11705923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
    Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
    J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.
    Quiding M; Nordström I; Kilander A; Andersson G; Hanson LA; Holmgren J; Czerkinsky C
    J Clin Invest; 1991 Jul; 88(1):143-8. PubMed ID: 1905327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of exogenous reproductive hormones on specific antibody production in genital secretions after vaginal vaccination with recombinant cholera toxin B subunit in humans.
    Wassen L; Jertborn M
    Clin Vaccine Immunol; 2006 Feb; 13(2):202-7. PubMed ID: 16467326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human gastric B cell responses can be induced by intestinal immunisation.
    Quiding-Järbrink M; Lönroth H; Ahlstedt I; Holmgren J; Svennerholm AM
    Gut; 2001 Oct; 49(4):512-8. PubMed ID: 11559648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humans.
    Jertborn M; Nordström I; Kilander A; Czerkinsky C; Holmgren J
    Infect Immun; 2001 Jun; 69(6):4125-8. PubMed ID: 11349086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
    Zavala-Spinetti L; Breslin MB; Correa H; Bégué RE
    Helicobacter; 2006 Dec; 11(6):517-22. PubMed ID: 17083372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.